RICHMOND, British Columbia, Nov. 29, 2006 (PRIME NEWSWIRE) -- BioCurex Inc. (OTCBB:BOCX) announced today that an interview with its CEO, Dr. Ricardo Moro is now available at http://smallcapdigest.net/archive/listserv/20061129-1.html
SmallCapdigest.net is a member of the TGR Group. In October of 2003, TGR Group LLC was paid a fee of $25,000 and one million newly issued restricted shares (approximately the equivalent of $150,000) by BioCurex for coverage of the Company over a 12 month period. Under SEC Rule 144, all one million issued restricted shares have been eligible for sale into the public market since October of 2004. In addition, on March 22, 2005, TGR entered into an extended agreement with BioCurex for a fee of 25,000 newly issued restricted shares and on July 1, 2006 TGR entered into another extended agreement with BioCurex for an additional 100,000 shares of newly issued, restricted stock.
About BioCurex:
BioCurex, Inc. is a biotechnology company that is developing products based on patented/proprietary technology in the areas of cancer diagnosis, imaging and therapy. The technology identifies a cancer marker known as RECAF(tm), which is found on malignant cells from a variety of cancer types but is absent in most normal or benign cells.
BioCurex has signed a licensing agreement with Abbott Laboratories for BioCurex's RECAF(tm) Cancer technology as outlined in a joint press release dated March 29, 2005. The release noted that the cancer marker RECAF(tm) has emerged as a potential biomarker that may be useful in the development of new cancer diagnostics tests. Preliminary studies from the investigators at BioCurex have reported a high level of clinical sensitivity and specificity for RECAF in many of the most common cancers, including prostate, breast, colorectal, lung and others.
To read more about the Company, please visit the News section in our web site (www.biocurex.com).
Note:
The Company has not authorized the release of this information in any form that contravenes the Communication Act and will not be responsible for unsolicited massive distribution of this material by e-mail or facsimile by unauthorized parties. Statements in this press release, which are not historical facts, are "forward-looking statements" within the meaning given to that term in the Private Securities Litigation Reform Act of 1995. The Company intends that such forward-looking statements be subject to the safe harbors created thereby. Since these statements involve risks and uncertainties and are subject to change at any time, the Company's actual results could differ materially from expected results.